Serum calprotectin and renal function decline in ANCA-associated vasculitides: a post hoc analysis of MAINRITSAN trial

OBJECTIVE: Serum calprotectin appears to be an interesting biomarker associated with renal vascular disease activity in antineutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV). The aim of this study was to assess whether serum calprotectin levels can predict decline in renal function in...

Descripción completa

Detalles Bibliográficos
Autores principales: Romand, Xavier, Paclet, Marie Hélène, Chuong, Minh Vu, Gaudin, Philippe, Pagnoux, Christian, Guillevin, Loïc, Terrier, Benjamin, Baillet, Athan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Vasculitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619089/
https://www.ncbi.nlm.nih.gov/pubmed/37903568
http://dx.doi.org/10.1136/rmdopen-2023-003477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619089/
https://www.ncbi.nlm.nih.gov/pubmed/37903568
http://dx.doi.org/10.1136/rmdopen-2023-003477

Ejemplares similares